Edition:
United States

Novartis AG (NOVN.S)

NOVN.S on Virt-X Level 1

82.48CHF
17 Aug 2018
Change (% chg)

CHF0.76 (+0.93%)
Prev Close
CHF81.72
Open
CHF82.20
Day's High
CHF82.58
Day's Low
CHF81.98
Volume
4,607,912
Avg. Vol
4,651,933
52-wk High
CHF88.30
52-wk Low
CHF71.84

Select another date:

Tue, Aug 14 2018

Photo

Novartis recruits new compliance head from Siemens after ethics stumbles

ZURICH Novartis has recruited a new chief ethics officer from Siemens after costly bribery scandals and a disputed $1.2 million contract with President Donald Trump's former lawyer that the Swiss drugmaker now calls a mistake.

Novartis recruits new compliance head from Siemens after ethics stumbles

* Novartis hires Siemens lawyer to lead anti-corruption efforts

BRIEF-Novartis appoints Klaus Moosmayer as Chief Ethics Risk and Compliance Officer

* SAYS NOVARTIS APPOINTS DR. KLAUS MOOSMAYER AS CHIEF ETHICS RISK AND COMPLIANCE OFFICER Further company coverage: (Reporting By Zurich newsroom)

BRIEF-Novartis Announces U.S. Renewables Agreement To Reduce Greenhouse Gas Emissions

* NOVARTIS ANNOUNCES US RENEWABLES AGREEMENT TO REDUCE GREENHOUSE GAS EMISSIONS

More drugmakers build Brexit stockpiles as EU agency faces exodus

PARIS/ZURICH/LONDON Sanofi and Novartis said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out of the European Union without a deal. | Video

More drugmakers build Brexit stockpiles as EU agency faces exodus

PARIS/ZURICH/LONDON Sanofi and Novartis said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out of the European Union without a deal.

UPDATE 3-More drugmakers build Brexit stockpiles as EU agency faces exodus

* Sanofi and Novartis action follows similar move by AstraZeneca

BRIEF-MerLion Regains North American Rights to XTORO

* MERLION PHARMACEUTICALS- NOVARTIS HAS MADE A PORTFOLIO DECISION AND TERMINATED LICENSE BETWEEN ALCON AND MERLION EXECUTED IN 2010

UPDATE 1-Trump thanks Novartis, Pfizer for not raising drug prices

WASHINGTON, July 19 U.S. President Donald Trump thanked two major drug companies on Thursday for not raising their prices and said his administration was working toward substantially cutting prescription-drug prices.

Trump thanks Novartis, Pfizer for not raising drug prices

WASHINGTON U.S. President Donald Trump on Thursday thanked two major drug companies for not raising their prices and said his administration was working toward "substantially" cutting prescription-drug prices.

Select another date: